Insulin Infusion Pumps Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Insulin Infusion Pumps Market By Product (Insulin Pumps, Infusion Sets, Reservoirs), By Types (Open-loop, Closed-loop), By End User (Hospitals, Individuals) and Geography.

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Insulin Infusion Pumps Market size was estimated at USD 12.2 Bn in 2021, growing at a CAGR of 8.9% during the forecast period 2021-2027. Insulin infusion pumps are the devices which are used to administer insulin in diabetes mellitus patients. Insulin infusion pumps administer the accurate dose of insulin into the body with less pain. Insulin pumps are working as alternative systems for insulin pen and daily insulin injection. Scheduling of mealtime is not required with the using of insulin infusion pumps. Insulin infusion pumps contain a pump, reservoir, tubing system, and disposable infusion set with a cannula for the subcutaneous insertion. These devices reduce the number of insulin daily injections with syringe or pen. Insulin Infusion Pumps Market is growing at a significant CAGR owing to increase in the technological advancements in the insulin devices. Increase in the prevalence of diabetes fuels the growth of insulin pumps market. According to the International Diabetes Federation (IDF), 7 Mn people are added every year to the pool of 246 million diabetics, which is projected to increase approximately 438 Mn by 2030. Patent approvals, product launchings, product approvals, innovation of novel products, and acquisitions are the strategies followed by the companies for strengthening position in the insulin infusion pumps market. For instance, Tandem Diabetes Care, Inc. filled a U.S. patent for the medical infusion pump with remote bolus feature. Moreover, in September 2016, Medtronic Minimed, Inc. received FDA approval for insulin infusion pump 670G system with continuous glucose monitoring system.

Insulin Infusion Pumps Market

MARKET SUMMARY
-
8.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.8%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Insulin Infusion Pumps Market

 

  • The report on global Insulin Infusion Pumps Market gives historical, current, and future market sizes (US$ Mn) on the basis of
    product type, diabetes type, end user and region.
  • global Insulin Infusion Pumps Market report gives comprehensive outlook across the region with special emphasis on key regions
    such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • In August 2017, Tandem Diabetes Care, Inc. launched t: slim X2 insulin pump with continuous glucose monitoring feature
  • In December 2016, Animas Corporation received Health Canada’s authorization and FDA approval for OneTouch Vibe Plus insulin pump with continuous glucose monitoring (CGM) system
Market Key Players
  • Insulet Corporation (U.S.)
  • Ypsomed (Switzerland)
  • Tandem Diabetes Care, Inc. (U.S.)
  • Animas Corporation (U.S.)
  • Cellnovo Group SA (France)
  • F. Hoffmann La Roche Ltd. (Switzerland)
  • Smiths Medical (U.S.)
  • Sooil developments Co., Ltd. (South Korea)
Drivers And Restraints

Insulin Infusion Pumps Market

Increase in the prevalence of diabetes, a rise in geriatric population, technological advancements of the devices, and ease of administration of insulin with infusion pumps are fuelling the insulin infusion pumps market. Furthermore, increase in the preference for home-based insulin therapy, accuracy in releasing of insulin dose, flexibility in meal scheduling and marketing activities by the market players are anticipated to propel the insulin infusion pumps market over the forecast period. However, product recalls, the high cost of devices, lack of awareness about insulin infusion pumps, and lack of reimbursement policies for insulin devices are the factors impeding the growth of Insulin Infusion Pumps Market.


North-America got significant share

Insulin Infusion Pumps Market

Geographically, the insulinInfusion Pumps Market is segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Increase in the prevalence of diabetes in North America majorly in U.S. (According to American Diabetes Association, the prevalence of diabetes in 2015 is 30.3 Mn or 9.4% in U.S.), a rise in the healthcare expenditure and technological advancements in insulin infusion pumps are driving the insulin pumps market in North America region. Europe insulin infusion pumps market is expected to fuel at significant rate over the forecast years owing to upsurge in the diabetes population majorly in Germany, Russia, and U.K (according to Diabetes UK 2016, about 3.6 Mn people are suffering from diabetes in the U.K. region), and adoption of modern technologies in Europe region. Moreover, Asia Pacific exhibiting significant growth which is attributed to increase in diabetes population majorly in India and China (according to the International Diabetes Federation, in 2015, in China around 96.2 million diabetic patients and in India 66.8 million patients are suffering from diabetes.), rise in healthcare expenditure, and adoption of novel insulin delivery device in Asia Pacific region are the factors expected to bolster the Insulin Infusion Pumps Market over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Segmentation

Insulin Infusion Pumps Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Insulin Infusion Pumps Market Introduction
2.1. Global Insulin Infusion Pumps Market – Taxonomy
2.2. Global Insulin Infusion Pumps Market –Definitions
2.2.1. By Product
2.2.2. By Types
2.2.3. By End Users
3. Global Insulin Infusion Pumps Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Insulin Infusion Pumps Market Dynamic Factors – Impact Analysis
3.6. Global Insulin Infusion Pumps Market – Competition Landscape
4. Global Insulin Infusion Pumps Market Analysis, 2017 – 2021 and Forecast, 2022- 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Insulin Infusion Pumps Market, By Product, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1. Insulin Pumps
5.1.1.  Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Infusion Sets
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Reservoirs
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Insulin Infusion Pumps Market Forecast, By Types, 2017 – 2021 and Forecast, 2022- 2028
6.1. Open Loop
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Closed Loop
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Insulin Infusion Pumps Market Forecast, By End Users, 2017 – 2021 and Forecast, 2022- 2028
7.1. Hospitals
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Individuals
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Insulin Infusion Pumps Market Forecast, By Region, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Insulin Infusion Pumps Market – Opportunity Analysis Index, By Product, By Types, End Users, and Country, 2022- 2028
9. North America Insulin Infusion Pumps Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
9.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Insulin Pumps
9.1.2. Infusion Sets
9.1.3. Reservoirs
9.2. Types Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Open-loop
9.2.2. Closed-loop
9.3. End Users Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Individuals
9.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Insulin Infusion Pumps Market – Opportunity Analysis Index, By Product, By Types, End Users, and Country, 2022- 2028
9.6. North America Insulin Infusion Pumps Market Dynamics – Trends
10. Europe Insulin Infusion Pumps Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
10.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Insulin Pumps
10.1.2. Infusion Sets
10.1.3. Reservoirs
10.2. Types Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Open-loop
10.2.2. Closed-loop
10.3. End Users Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Individuals
10.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Insulin Infusion Pumps Market – Opportunity Analysis Index, By Product, By Types, End Users, and Country, 2022- 2028
10.6. Europe Insulin Infusion Pumps Market Dynamics – Trends
11. Asia-Pacific Insulin Infusion Pumps Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
11.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Insulin Pumps
11.1.2. Infusion Sets
11.1.3. Reservoirs
11.2. Types Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Open-loop
11.2.2. Closed-loop
11.3. End Users Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Individuals
11.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Insulin Infusion Pumps Market – Opportunity Analysis Index, By Product, By Types, End Users, and Country, 2022- 2028
11.6. Asia-Pacific Insulin Infusion Pumps Market Dynamics – Trends
12. Latin America Insulin Infusion Pumps Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
12.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Insulin Pumps
12.1.2. Infusion Sets
12.1.3. Reservoirs
12.2. Types Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Open-loop
12.2.2. Closed-loop
12.3. End Users Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Individuals
12.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Insulin Infusion Pumps Market – Opportunity Analysis Index, By Product, Types, End Users, and Country, 2022- 2028
12.6. Latin America Insulin Infusion Pumps Market Dynamics – Trends
13. Middle East and Africa Insulin Infusion Pumps Market Analysis, 2017 – 2021 and Forecast, 2022- 2028 (Revenue, USD Mn)
13.1. Product Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Insulin Pumps
13.1.2. Infusion Sets
13.1.3. Reservoirs
13.2. Types Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Open-loop
13.2.2. Closed-loop
13.3. End Users Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Individuals
13.4. Country Analysis 2017 – 2021 and Forecast 2022- 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Insulin Infusion Pumps Market – Opportunity Analysis Index, By Product, Types, End Users, and Country, 2022- 2028
13.6. MEA Insulin Infusion Pumps Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Medtronic
14.2.2. Diabeloop
14.2.3. Roche
14.2.4. Animas
14.2.5. Ypsomed
14.2.6. Insulet
14.2.7. Others
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Insulet Corporation (U.S.)
  • Ypsomed (Switzerland)
  • Tandem Diabetes Care, Inc. (U.S.)
  • Animas Corporation (U.S.)
  • Cellnovo Group SA (France)
  • F. Hoffmann La Roche Ltd. (Switzerland)
  • Smiths Medical (U.S.)
  • Sooil developments Co., Ltd. (South Korea)

Description

Insulin Infusion Pumps Market size was estimated at USD 12.2 Bn in 2021, growing at a CAGR of 8.9% during the forecast period 2021-2027. Insulin infusion pumps are the devices which are used to administer insulin in diabetes mellitus patients. Insulin infusion pumps administer the accurate dose of insulin into the body with less pain. Insulin pumps are working as alternative systems for insulin pen and daily insulin injection. Scheduling of mealtime is not required with the using of insulin infusion pumps. Insulin infusion pumps contain a pump, reservoir, tubing system, and disposable infusion set with a cannula for the subcutaneous insertion. These devices reduce the number of insulin daily injections with syringe or pen. Insulin Infusion Pumps Market is growing at a significant CAGR owing to increase in the technological advancements in the insulin devices. Increase in the prevalence of diabetes fuels the growth of insulin pumps market. According to the International Diabetes Federation (IDF), 7 Mn people are added every year to the pool of 246 million diabetics, which is projected to increase approximately 438 Mn by 2030. Patent approvals, product launchings, product approvals, innovation of novel products, and acquisitions are the strategies followed by the companies for strengthening position in the insulin infusion pumps market. For instance, Tandem Diabetes Care, Inc. filled a U.S. patent for the medical infusion pump with remote bolus feature. Moreover, in September 2016, Medtronic Minimed, Inc. received FDA approval for insulin infusion pump 670G system with continuous glucose monitoring system.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX